Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate
Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus